Your SlideShare is downloading. ×
0
Causality in pharmacoepidemiologic research           what are the challenges?         Rolf H.H. Groenwold, MD, PhD
Wikipedia:“Pharmacoepidemiology is the study of the use of  and the effects of drugs in large numbers of  people”“Pharmaco...
Randomized trials….... are the paradigm to assess the effects of drug,yet…… are very expensive… require a lot of men power...
Non-randomized trials….… are MUCH LESS expensive… require LESS men power… answer MORE than 1 question… are MORE informativ...
Confounding – an example of EPO                   VS.
An example of influenza vaccination“Studies naar het effect  van vaccinatie tegen  griep deugen vaak  methodologisch niet....
ConfoundingThe everlasting challenge in pharmacoepidemiology- can be addressed by comparing like with like   - E.g. compar...
Some challenges:1. (non-)positivity2. Dynamic treatment3. Validity and completeness of registries
(non-)positivity – example Study of OC use in medical students:                    Oral contraceptive No oral  Confounder ...
1. (non-)positivity in pharmacoepi• non-positivity shortly after drug comes to the market   (selective groups switch treat...
2. Dynamic treatment in pharmacoepiTreatment is often not a constant• time-varying dosage• on demand treatment (e.g. SABA,...
3. Registries in pharmacoepi Validity and completeness of registries • prescription ≠ actual drug use • only measured conf...
Causality in pharmacoepidemiologyPharmacoepidemiology is an ideal playing field tostudy methods for causal inference.A lot...
Thank you for your attention
Upcoming SlideShare
Loading in...5
×

Groenwold causality leiden - 5 oct2012

932

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
932
On Slideshare
0
From Embeds
0
Number of Embeds
2
Actions
Shares
0
Downloads
2
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Transcript of "Groenwold causality leiden - 5 oct2012"

  1. 1. Causality in pharmacoepidemiologic research what are the challenges? Rolf H.H. Groenwold, MD, PhD
  2. 2. Wikipedia:“Pharmacoepidemiology is the study of the use of and the effects of drugs in large numbers of people”“Pharmacoepidemiology is the bridge between pharmacology and epidemiology”“Pharmacoepidemiology studies the effects ofdrugs”http://en.wikipedia.org/wiki/Pharmacoepidemiology
  3. 3. Randomized trials….... are the paradigm to assess the effects of drug,yet…… are very expensive… require a lot of men power… answer (at most) only 1 question… are little informative about (rare) side-effects… have limited duration of follow-up
  4. 4. Non-randomized trials….… are MUCH LESS expensive… require LESS men power… answer MORE than 1 question… are MORE informative about (rare) side-effects… have ENDLESS duration of follow-up, yet…... are NOT the paradigm to assess the effects ofdrug, because …
  5. 5. Confounding – an example of EPO VS.
  6. 6. An example of influenza vaccination“Studies naar het effect van vaccinatie tegen griep deugen vaak methodologisch niet.” (www.nos.nl, 24-10-2011)“Effectiviteit griepprik nooit bewezen” (Elsevier, 24-10-2011)
  7. 7. ConfoundingThe everlasting challenge in pharmacoepidemiology- can be addressed by comparing like with like - E.g. compare treated men with untreated men and treated women with untreated women- all methods to control for confounding are based on this principle
  8. 8. Some challenges:1. (non-)positivity2. Dynamic treatment3. Validity and completeness of registries
  9. 9. (non-)positivity – example Study of OC use in medical students: Oral contraceptive No oral Confounder use contraceptive use Females 95% 5% Males 0% 100% Study of β-blocker use in adults β-blocker use No β-blocker use Confounder Hypertension 30% 70% No hypertension 0.5% 99.5%
  10. 10. 1. (non-)positivity in pharmacoepi• non-positivity shortly after drug comes to the market (selective groups switch treatment)• second choice drugs (non-respondents switch treatment)• strict indication (yet unrecorded)
  11. 11. 2. Dynamic treatment in pharmacoepiTreatment is often not a constant• time-varying dosage• on demand treatment (e.g. SABA, NSAIDs)• ‘ever vs never’ or dynamic regimes (where does our interest lie?)
  12. 12. 3. Registries in pharmacoepi Validity and completeness of registries • prescription ≠ actual drug use • only measured confounders can be adjusted • time-varying confounding (how frequent have confounders been measured?) Shouldn’t we anticipated future research in designing our registries? (which are key confounders?)
  13. 13. Causality in pharmacoepidemiologyPharmacoepidemiology is an ideal playing field tostudy methods for causal inference.A lot of opportunities and challenges.
  14. 14. Thank you for your attention
  1. A particular slide catching your eye?

    Clipping is a handy way to collect important slides you want to go back to later.

×